Skip to content
10-Q

Quarterly Report

SURFACE ONCOLOGY, INC.

0001718108-22-000019

← back to feed
Filed
Aug 3, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Aug 1, 2022 58.03M sh
Cash And Equivalents Q2 2022 · Jun 30, 2022 $74.82M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $56.05M
Current Liabilities Q2 2022 · Jun 30, 2022 $19.73M
Current Liabilities Q2 2022 · Dec 31, 2021 $20.02M
Total Liabilities Q2 2022 · Jun 30, 2022 $68.26M
Total Liabilities Q2 2022 · Dec 31, 2021 $71.95M
Current Assets Q2 2022 · Jun 30, 2022 $161.51M
Current Assets Q2 2022 · Dec 31, 2021 $157.35M
Total Assets Q2 2022 · Jun 30, 2022 $193.98M
Total Assets Q2 2022 · Dec 31, 2021 $190.85M
Shares Diluted Q2 2022 · Jun 30, 2021 43.63M sh
Shares Diluted Q2 2022 · Jun 30, 2021 42.63M sh
Capex Q2 2022 · Jun 30, 2021 $0
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$31.23M
Stockholders Equity Q2 2022 · Jun 30, 2021 $148.09M
Stockholders Equity Q2 2022 · Mar 31, 2021 $159.05M
Stockholders Equity Q2 2022 · Dec 31, 2020 $155.75M
Eps Diluted Q2 2022 · Jun 30, 2021 −$0.44
Eps Diluted Q2 2022 · Jun 30, 2021 −$0.81
Eps Basic Q2 2022 · Jun 30, 2021 −$0.44
Eps Basic Q2 2022 · Jun 30, 2021 −$0.81
Rd Expense Q2 2022 · Jun 30, 2021 $12.67M
Rd Expense Q2 2022 · Jun 30, 2021 $23.21M
Net Income Q2 2022 · Jun 30, 2021 −$18.98M
Net Income Q2 2022 · Jun 30, 2021 −$34.54M
Net Income Q2 2022 · Mar 31, 2021 −$15.56M
Operating Income Q2 2022 · Jun 30, 2021 −$18.59M
Operating Income Q2 2022 · Jun 30, 2021 −$33.15M
Revenue Q2 2022 · Jun 30, 2021 $515K
Revenue Q2 2022 · Jun 30, 2021 $2.14M